Today: 16 April 2026
TQQQ Slides Toward $40 as Nasdaq Correction Tests Leveraged QQQ Trade
27 March 2026
1 min read

TQQQ Slides Toward $40 as Nasdaq Correction Tests Leveraged QQQ Trade

NEW YORK, March 27, 2026, 10:38 EDT

ProShares UltraPro QQQ, the leveraged ETF popular for amplifying Nasdaq-100 moves, hovered near $40 in Friday’s session after tumbling 7.1% the day before. Shares were changing hands at $39.67 as of 10:28 a.m. EDT, off from Thursday’s close at $41.23, with 117.6 million shares moving on that day. For comparison, QQQ—the plain-vanilla Nasdaq-100 fund—was off roughly 1.0% in early action.

Here’s why that matters: TQQQ aims for triple the Nasdaq-100’s daily move, before fees kick in. ProShares cautions the fund’s longer-term performance can veer far from that target, particularly if volatility ramps up.

The warning takes on extra weight now, with market conditions deteriorating. On Thursday, Reuters said the Nasdaq Composite slid 2.4%, pushing it almost 11% off its October high—firmly into correction territory, which is Wall Street’s term for a decline of 10% or more from a recent peak.

Not much letup on Friday. Brent crude tacked on 2.5%, settling at $110.70 a barrel. Over in bonds, the benchmark 10-year U.S. Treasury yield moved up to 4.468%. The dollar index edged higher, too, up 0.2% as investors parsed the Iran conflict and braced for another possible inflation jolt.

Steve Sosnick at Interactive Brokers pointed to a clear “erosion in market enthusiasm” after the outbreak of hostilities. Hargreaves Lansdown’s Matt Britzman added that investors are waiting for “tangible evidence of progress” to see sentiment stabilize. Reuters

The wild swing in TQQQ comes down to how it’s built. On March 26, ProShares listed hefty Nasdaq-100 swap positions plus big bets on Nvidia, Apple, Microsoft, and Amazon. Those direct holdings make TQQQ especially sensitive to the same tech heavyweights already feeling the heat.

Pain rippled beyond a single stock. SQQQ, the leveraged inverse ETF, jumped 3.1% Friday morning. QLD, the 2x bull fund, slipped 2.0%, and SOXL, which zeroes in on semiconductors, dropped 2.2%. Geared growth names were swinging more sharply than the underlying market.

This trade can shift in a heartbeat. Jim Carroll at Ballast Rock Private Wealth pointed out that the week’s decline wasn’t exactly a steady drop — and markets, he said, remain “one headline” from surging higher. Leveraged funds, he added, are just as quick to yank bulls and bears in either direction. Reuters

Next week, the spotlight shifts to fresh data. Reuters reports that traders have their eyes on U.S. retail sales, factory numbers, and the March payrolls, with economists predicting 48,000 jobs gained. James Ragan at D.A. Davidson flagged “a lot of uncertainty out there overall” as the quarter wraps up. Reuters

Right now, TQQQ is a case study in leveraged QQQ exposure during a downturn: losses cut deeper, moves get sharper, and mistakes get punished harder. Designed to turbocharge daily Nasdaq upside, the fund’s just ended up magnifying a correction driven by surging oil, rising yields, and fading risk appetite.

Stock Market Today

  • Anthropic launches Claude Opus 4.7 amid tense AI rivalry with OpenAI
    April 16, 2026, 4:39 PM EDT. Anthropic released Claude Opus 4.7 as the competition with OpenAI intensifies. OpenAI's chief revenue officer Denise Dresser criticized Anthropic's $30 billion revenue run rate, claiming it is inflated by nearly $8 billion due to accounting methods involving revenue shares with Amazon and Google. Anthropic's rapid growth, tripling since 2025, contrasts with OpenAI's concerns about Anthropic's narrow focus on coding products and insufficient cloud compute capacity. OpenAI stresses the importance of enterprise trust and flexibility, highlighting its expanded $50 billion AWS deal and exclusive cloud platform, OpenAI Frontier. This battle underscores evolving enterprise AI dynamics as players seek broader adoption beyond developer tools.

Latest article

Hims & Hers Health Stock Jumps as FDA Reconsiders Peptide Restrictions

Hims & Hers Health Stock Jumps as FDA Reconsiders Peptide Restrictions

16 April 2026
Hims & Hers Health shares rose to $26.65 Thursday after the FDA said it would reconsider restrictions on several peptides, removing 12 from a high-risk list and scheduling a July review of seven more. The move follows Hims’ March decision to stop advertising compounded GLP-1 drugs and expand branded offerings through Novo Nordisk. The company acquired a California peptide facility last year to bolster supply.
NuScale Power Stock Whipsaws After U.S. Opens Door to Nuclear Loans, Space Reactor Push

NuScale Power Stock Whipsaws After U.S. Opens Door to Nuclear Loans, Space Reactor Push

16 April 2026
NuScale Power shares jumped to $13.23 before falling back to $11.52 Thursday after the White House ordered NASA to start a space-reactor program and Energy Secretary Chris Wright said initial U.S. reactors would likely get federal loans. NuScale remains the only U.S. firm with an approved small modular reactor design but has yet to secure firm orders or financing.
SoFi Technologies Stock Rises as FedNow Instant Transfers Set Up April 29 Earnings Test

SoFi Technologies Stock Rises as FedNow Instant Transfers Set Up April 29 Earnings Test

16 April 2026
SoFi Technologies shares rose 1.5% Thursday after launching instant bank transfers via its Galileo platform, allowing money to move between SoFi and outside banks in seconds. The stock traded near $19.08 in New York. Investors await first-quarter results April 29, with SoFi guiding to $1.04 billion in adjusted net revenue and 12 cents per share in adjusted earnings.
D-Wave Quantum Stock Jumps Again as Nvidia’s Ising Launch Reignites Quantum Rally

D-Wave Quantum Stock Jumps Again as Nvidia’s Ising Launch Reignites Quantum Rally

16 April 2026
D-Wave Quantum shares climbed about 5% Thursday, extending a 22.6% surge after Nvidia launched Ising, a new AI model family for quantum computing. D-Wave traded at $21.81, up from last year’s lows, and reported 2025 revenue of $24.6 million with first-quarter 2026 bookings topping $32.8 million. The company completed its $250 million Quantum Circuits acquisition in January. Market cap stood near $8.4 billion.
Meta and Alphabet Stocks Slide Again After Social Media Addiction Verdicts Raise Liability Fears
Previous Story

Meta and Alphabet Stocks Slide Again After Social Media Addiction Verdicts Raise Liability Fears

Microsoft Stock Heads for Worst Stretch Since 2009 as OpenAI, Copilot Worries Deepen
Next Story

Microsoft Stock Heads for Worst Stretch Since 2009 as OpenAI, Copilot Worries Deepen

Go toTop